StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Share price is a very poor indicator...

<< Previous

Bullboard Posts

Next >>

Post by gojotv!on Apr 21, 2022 8:14pm

199 Views

Post# 34622385

Share price is a very poor indicator...

...of a company's quality.
Share price is really an indicator of the intelligence of speculators, which as we have seen by Like2Bash, and TrippingAllOverMyselfAgain's posts is very low and poor indeed.
This is a long and steady play, especially as the post-Covid world opens up.
Phenomenal potential. Are you ready?
GLTA!